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Background. Thymidine analog 5-ethynyl-2-deoxyuridine (EdU) has recently been used for tracking mesenchymal stem cells
(MSCs). In the present study, we tested whether EdU was cytotoxic and whether it interfered with differentiation, cytokine
secretion and migration of MSCs.Methods. EdU labeling was performed by incubating adipose-derived stem cells (ADSCs)
with 10−8 mol/L of EdU for 48 h. Incorporation of EdU was detected by reaction with azide-conjugated Alexa594. The
labeled and unlabeled ADSCs were compared for proliferation and apoptosis as determined by CellTiter and comet assays,
respectively. They were also compared for neuron-like and endothelial differentiation as determined by morphology, marker
expression and function. Comparison of their secreted cytokine profile was performed by cytokine antibody array.
Comparison of their response to homing factor SDF-1 was performed by migration assay. Results. EdU was incorporated into
the nucleus in approximately 70% of ADSCs. No significant differences in proliferation and apoptosis rates were observed
between EdU-labeled and unlabeled ADSCs. Isobutylmethylxanthine induced both EdU-labeled and unlabeled ADSCs to
assume a neuron-like morphology and to express b-III tubulin. Endothelial growth medium-2 (EGM2) induced endothelial
differentiation in both EdU-labeled and unlabeled ADSCs, including the ability to uptake low-density lipoprotein and to
form capillary-like structures as well as the expression of vWF, eNOS and CD31. EdU-labeled and unlabeled ADSCs
exhibited identical secreted cytokine profile and identical migratory response to SDF-1. Discussion. At the recommended
dosage of 10−8 mol/L, EdU is non-toxic to ADSCs. EdU label did not interfere with differentiation, cytokine secretion or
migratory response to SDF-1 by ADSCs.
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Thymidine analogs have been used extensively for
the analysis of cellular DNA synthesis, tracking of
transplanted cells and identification of tissue-resi-
dent stem cells (1e4). The importance of these
thymidine analogs in biomedical research is best
exemplified by the utilization of 5-bromo-2-deoxy-
uridine (BrdU) in more than 20,000 peer-reviewed
studies (1). However, the histological detection of
BrdU requires harsh conditions that affect cellular
structure and protein anti-genicity. In addition, the
resulting histological images can be difficult to assess
because of low signal-versus-noise ratio. As such, in
2008, Salic and Mitchison (5) introduced a new
thymidine analog, 5-ethynyl-20-deoxyuridine (EdU),
which can be easily detected without affecting
cellular structure or protein anti-genicity. In 2009,
we reported for the first time the use of EdU for the
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(ADSCs) (2). We have since used this method to
track transplanted ADSCs in several preclinical
studies, for example, in a rat model of stress urinary
incontinence (3). We have also used it for the
detection of potential tissue-resident stem cells by
means of the “label-retaining cell” strategy (4). In
studies that examined possible cellular differentiation
of transplanted ADSCs, we occasionally observed
smooth muscle or endothelial differentiation, based
on the co-localization of the EdU label with specific
cell lineage markers (3,6,7). However, such co-
localization occurred only rarely, and therefore we
proposed that therapeutic effects of ADSCs might
derive from its paracrine action rather than cellular
differentiation (3,8,9). However, it has been shown
that BrdU was cytotoxic and inhibited cell differen-
tiation and migration (10,11). Thus, it is possible
that the infrequent cellular differentiation of trans-
planted ADSCs was a consequence of EdU labeling.ifornia, San Francisco, CA 94143-0738, USA. E-mail: clin@urology.ucsf.edu
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labeling did not have adverse effects on ADSCs (12).
Therefore, amid these conflicting reports on the
adverse effects of BrdU (or lack of), the present
study aimed at testing whether EdU labeling affects
cell proliferation, apoptosis, cytokine secretion,
differentiation and migration.
Methods
EdU labeling of ADSCs
Isolation and culture of rat ADSCs have been
described previously (3). Cells at the fourth passage
were used in the present study. For EdU labeling,
1  105 cells were seeded in each well of a six-well
plate in Dulbecco modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine
serum (FBS). Twenty-four h later, EdU (Invitrogen,
Carlsbad, CA, USA) was added to the medium at
10−8 mol/L. Another 48 h later, cells were fixed for
EdU staining or for further tests. For EdU staining,
the cells were fixed with methanol, washed twice with
phosphate-buffered saline (PBS), incubated in 3%
bovine serum albumin in PBS and then incubated in
0.5% Triton X-100 in PBS for 20 min at room
temperature. The cells were then incubated with
freshly made Click-iT reaction cocktail, which con-
tained azide-conjugated Alexa594 (Invitrogen), for
30 min at room temperature in the dark. The
cells were further stained with 40,6-diamidino-2-
phenylindole (DAPI, for nuclear staining, 1 mg/mL,
Sigma-Aldrich, St. Louis, MO, USA) and then
mounted in standard mounting media. The stained
cells were examined with a Nikon Eclipse E600
fluorescence microscope and photographed with
a Retiga 1300 Q-imaging camera. For determination
of the percentage of EdU-positive cells, the number
of red-fluorescent (Alexa594-stained) cells was
divided by the number of blue-fluorescent (DAPI-
stained) cells. The experiment was performed in
triplicate. Data presented in Results are the average
of three independent experiments.
Proliferation assay
EdU-labeled or unlabeled ADSCs were seeded into
a 96-well plate at 2000 cells per well in DMEM with
10% FBS and incubated at 37C. At 0, 24, 48, 72
and 96 h, 10 mL of CellTiter-96 reagent (Promega
Inc., Madison, WI, USA) was added to each well.
After 1 h of further incubation at 37C, the cells
were scanned in a plate reader (Molecular Devices
Corp., Sunnyvale, CA, USA) at 490-nm absorbance.
All assays were performed in triplicate. All data
presented in Results are the average of three inde-
pendent experiments.Apoptosis assay
Cellular apoptosis was analyzed by the CometAssay
Electrophoresis Systems (Trevigen, Inc., Gaithers-
burg, MD, USA). Briefly, 50 mL (5000 cells) of EdU-
labeled or unlabeled ADSCs in PBS were mixed with
500 mL of molten low-melting agarose at 37C. An
aliquot of 75 mL of the mixture was immediately
pipetted and spread evenly onto a CometSlide (Tre-
vigen). The slide was then placed in a refrigerator for
10e30 min and immersed in pre-chilled lysis solution
for another 30e60 min. Afterward, the slide was
immersed in freshly prepared alkaline solution for
20e60 min at room temperature in the dark. The
slide was then washed with Tris-borate-EDTA (TBE)
buffer twice for 5 min each and electrophoresed in
TBE at 1 v/cm for 10 min. Afterward, the slide was
dipped in 70% ethanol for 5 min and air-dried (until
the agarose became dry). An aliquot of 50 mL of
diluted SYBR green I (Trevigen) was then added onto
each well of the dried agarose. The slide was then
observed with a Nikon Eclipse E600 fluorescence
microscope (Nikon Instruments Inc., Melville, NY,
USA) and photographed with a Retiga 1300 camera
(QImaging, Burnaby, BC, Canada). For determina-
tion of the percentage of apoptotic cells, the number
of cells with comet tail (indication of apoptosis) was
divided by the number of all cells. The experiment
was performed in triplicate. Data presented in Results
are the average of three independent experiments.
In vitro neuronal differentiation
ADSC neuron-like differentiation was performed as
previously described (13). Briefly, EdU-labeled or
unlabeled ADSCs were seeded into a six-well plate at
5  105 cells per well in DMEM with 10% FBS. The
next day, the cells were washed three times with PBS
and the medium changed to DMEM supplemented
with 5 10−8 mol/L isobutylmethylxanthine (IBMX)
(Sigma-Aldrich). One hour later, the cells were
stained for the presence of EdU and for neuron-
specific marker b-III tubulin (14) (using antieb-III
tubulin antibody from Abcam, Inc., Cambridge, MA,
USA), followed by nuclear stain with DAPI.
In vitro endothelial differentiation
ADSC endothelial differentiation was performed as
previously described (7). Briefly, EdU-labeled or
unlabeled ADSCs were seeded into a six-well plate at
5  105 cells per well in DMEM with 10% FBS. The
next day, the culture medium was replaced with
EGM2 (Lonza Biologics Inc., Portsmouth, NH,
USA), and the cells further incubated for 7 days with
the medium replenished every 3 days. The cells were
then analyzed for endothelial marker expression and
Figure 1. EdU labeling efficiency and effects on proliferation and apoptosis of ADSCs. (A) ADSCs were labeled with EdU at 10−8 mol/L for
48 h and stained with azide-conjugated Alexa594 (red fluorescence) and DAPI (blue fluorescence). Original magnification was 200. (B)
Proliferation of EdU-labeled and unlabeled ADSCs was assessed by CellTiter at the indicated time points. (C) Apoptosis of EdU-labeled
and unlabeled ADSCs was assessed by CometAssay. Representative images are shown on the left with arrows pointing at apoptotic cells. The
number of apoptotic cells as a percentage of total cells is shown in the bar chart on the right.
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marker expression, the cells were stained for the
presence of EdU and by antibodies against endo-
thelial-specific markers CD31 (Abcam), vWF
(Abcam) and eNOS (15) (BD Biosciences, San Jose,
CA, USA), followed by nuclear stain with DAPI.
Immunofluorescence staining
Cells were fixed in cold methanol for 5 min at 4C,
permeabilizedwith 0.05%TritonX-100 for 5min and
blocked with 5% normal equine serum in PBS for 1 h
at room temperature. The cells were then incubated
with primary antibody for 1 h at room temperature.
After washing with PBS three times, the cells were
incubated with Texas rede or fluorescein iso-
thiocyanateeconjugated secondary antibody for
another hour at room temperature. After three washes
with PBS, the cells were further stained with DAPI.Low-density lipoprotein uptake
Low-density lipoprotein (LDL) uptake was per-
formed as previously described (7). Briefly, cells were
seeded into six-well plates at 5  104 cells per well in
3 mL of EGM2 and incubated at 37C. The next
day, 10 mg/mL of DiI-conjugated acetylated LDL
complex (DiI-AcLDL, Invitrogen) was added to the
culture medium. The next day, after the medium was
removed, the cells were washed three times with
PBS, examined by phase-contrast and fluorescence
microscopy and photographed. Quantification of
LDL uptake (in pixel number) in each well was
performed on photographic images of nine randomly
chosen fields at 200 magnification, using Image-
Pro Plus 5.1 (Media Cybernetics, Silver Spring, MD,
USA). The experiment was performed in triplicate.
Data presented in Results are the average of three
independent experiments.
Figure 2. Effects of EdU labeling on neuron-like differentiation of ADSCs. EdU-labeled and unlabeled ADSCs were induced to
differentiate into neuron-like cells by IBMX and stained for the presence of EdU (red fluorescence) and for b-III tubulin (green
fluorescence), followed by nuclear stain with DAPI (blue fluorescence). Original magnification was 200.
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This assay was performed as previously described (7)
and was initiated by coating a 12-well culture plate
with 300 mL of growth factorereduced Matrigel (BD
Biosciences) per well. Approximately 1.5  105 cells
in 1 mL of EGM2 were then seeded into each well
and incubated at 37C. Sixteen h later, development
of capillary-like networks was examined by phase-
contrast microscopy and photographed. Endotubes
were quantified by counting their numbers in nine
random fields per sample under the microscope
(50). The experiment was performed in triplicate.
Data presented in Results are the average of three
independent experiments.Cytokine antibody array
An antibody-based cytokine array system (RayBio
Rat Cytokine Antibody Array 1, RayBiotech,
Norcross, GA, USA) was used to detect cytokines in
the culture medium of EdU-labeled or unlabeled
ADSCs, as previously described (16). Briefly, the
cells were cultured in 10% FBS-supplemented
DMEM in six-well dishes to 80% confluence. The
culture medium was then changed to serum-free
DMEM. Twenty-four h later, the medium was
collected and centrifuged at 13,000g for 10 s. The
supernatant was recovered and used in the array
experiment as follows. The array membrane was
placed in an eight-well tray and incubated in 4 mL of
1 blocking buffer for 45 min at room temperature.
Each test sample (2 mL of cell culture medium) was
added to the membrane, which was then shaken for 2
h at room temperature. After the membrane was
washed three times, a cocktail of biotinated anti-
cytokine antibodies was added and the reaction was
allowed to proceed for 1 h at room temperature on
the shaker. After the membrane was washed threetimes, horseradish-conjugated streptavidin was
added and the reaction was allowed to proceed for 1
h at room temperature on the shaker. Finally, the
membrane was washed as above, incubated in
enhanced chemiluminescence detection regents
(Amersham Life Sciences Inc., Arlington Heights,
IL, USA) for 5 min and exposed to Kodak autora-
diography film for 1e15 min.Cell migration assay
SDF-1aeinduced migration of EdU-labeled or
unlabeled ADSCs was assessed by using 24-well
BioCoat with an 8-mm pore size (BD Biosciences), as
previously described (17). Briefly, 500 mL of DMEM
containing 1% FBS and 0 or 100 ng/mL of SDF-1a
(R&D Systems, Inc., Minneapolis, MN, USA) was
added to the lower chamber, and 300 mL of DMEM
containing 1  104 ADSCs was added to the upper
chamber. After incubation for 24 h at 37C in
a humidified atmosphere with 5% CO2, migrated
cells, which adhered to the lower surface of a glass
cover slide, were stained with calcein (Invitrogen) for
10 min and manually counted in eight random
microscopic fields. The experiment was performed in
triplicate. Data presented in Results are the average
of three independent experiments.Statistical analysis
Data were analyzed with Prism 5 (GraphPad
Software, Inc., San Diego, CA, USA) and expressed
as mean  standard error of the mean for continuous
variables. The continuous data were compared
among the groups by means of one-way analysis of
variance. The Tukey-Kramer test was used for post
hoc comparisons. Statistical significance was set at
P < 0.05.
Figure 3. Effects of EdU labeling on endothelial differentiation of ADSCs. EdU-labeled and unlabeled ADSCs were induced to differentiate
into endothelial cells as verified by (A) the expression of endothelial markers CD31, vWF (green fluorescence) and eNOS (red fluorescence);
(B) LDL uptake (red fluorescence); and (C) tube formation. Blue fluorescence in (A) indicates cell nuclei. Quantitative data of LDL uptake
and tube formation are shown in the bar charts on the rightmost column of (B) and (C), respectively.
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EdU labeling did not inhibit cell proliferation or increase
cell death
Incubation of ADSCs with 10−8 mol/L EdU for 48 h
resulted in the incorporation of EdU in the nucleus
of approximately 70% of cells (Figure 1A). When
labeled cells were compared with unlabeled cells for
proliferation rate, no statistical difference was noted
(Figure 1B). Likewise, no statistical difference in
apoptosis rate was observed between labeled and
unlabeled cells (Figure 1C).EdU labeling did not affect the ability of ADSCs to
differentiate
When ADSCs were treated with 5  10−8 mol/L
IBMX, they assumed the morphology of neuron-likecells with extensive intercellular networks and
stained positive for neuronal marker b-III tubulin.
These phenotypical changes occurred in both EdU-
labeled and unlabeled ADSCs (Figure 2). When
ADSCs were grown in EGM2, they expressed
endothelial markers vWF, eNOS and CD31
(Figure 3A). They also acquired the ability to uptake
LDL and to form capillary-like tubular structures
(Figure 3B,C). These endothelial phenotypes were
displayed by both EdU-labeled and unlabeled
ADSCs (Figure 3).
EdU labeling did not affect the secreted cytokine profile
of ADSCs
Secretion of a panel of 19 different cytokines was
analyzed by an antibody-based array, and the results
show little or no difference between EdU-labeled and
unlabeled ADSCs (Figure 4).
Figure 4. Effects of EdU labeling on cytokine secretion of ADSCs.
EdU-labeled and unlabeled ADSCs were analyzed for cytokine
secretion by the RayBio Rat Cytokine Antibody Array, whose key
is shown at the bottom. Cytokine LIX (CXCL5) is circled in the
key to highlight the characteristic high-level secretion of this
cytokine by ADSCs.
Figure 5. Effects of EdU labeling on migratory response of
ADSCs toward SDF-1a. EdU-labeled and unlabeled ADSCs
were analyzed for migratory response to SDF-1a by using
24-well BioCoat with an 8-mm pore size. The migrated cells were
visualized by calcein stain and counted. The number of migrated
cells was averaged from three independent experiments.
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EdU-labeled and unlabeled ADSCs were analyzed
for their migratory response to homing factor
SDF-1a; the results show no statistical difference
(Figure 5).Discussion
Several different labels have been used for tracking
transplanted cells; however, most of them are prob-
lematic because of “leakage,” cytotoxicity and/or
detection difficulties (18,19). EdU is a recently
developed label that is easy to use and can be detected
without ambiguity (5). However, because of its
nascency, whether EdU labeling has adverse effects
remains unexplored. In our earlier studies with EdU
labeling, we chose a labeling time of 24 h or overnight,
and this resulted in a labeling rate of approximately
50% (2,6). In our more recent studies, we changed
the labeling time to 48 h (8,20), and this resulted in
a labeling rate of approximately 70%. Although this
change of labeling time has been mentioned in some
of our published studies (8,20), the actual data are
presented for the first time in the present study. More
importantly, we found that EdU-labeled ADSCs
were able to proliferate at the same rate as unlabeled
ADSCs, and they also underwent apoptosis at the
same rate as unlabeled ADSCs. These findings
suggest that, when used at the recommended dosage
of 10−8 mol/L, EdU is non-cytotoxic.One of the purposes of using labeled stem cells
(SCs) is to determine whether SCs can differentiate
into certain cell types after transplantation. However,
many studies, including ours, have not been able to
convincingly demonstrate such differentiations (9).
This raised the possibility that the labels may impede
SC differentiation, and, as such, in the present study
we investigated whether EdU had this adverse effect.
For induction of neuronal differentiation in vitro, we
repeated our previously published protocol in which
IBMX was the inducing agent (13,21). Like most
other neuronal induction methods, our procedure
resulted in the morphological transformation of SCs
into neuron-like cells and the expression of neuronal
markers such as b-III tubulin. Importantly, we found
that both EdU-labeled and unlabeled ADSCs were
able to undergo such neuron-like differentiation. For
induction of endothelial differentiation in vitro, we
repeated our previously published protocol in which
EGM2 medium was the inducing agent (7). The
results were reproducible, including the expression
of endothelial markers (vWF, eNOS and CD31) and
acquirement of endothelial functions (LDL uptake
and tube formation) in the EGM2-treated ADSCs.
More importantly, we observed no discernible
difference between EdU-labeled and unlabeled
ADSCs in any of these tests.
The scarcity of evidence for in vivo differentiation
of SCs has prompted the consideration that the
therapeutic efficacy of SCs might derive from their
paracrine actions (9). In the case with ADSCs, we
have previously shown that these cells’ neuro-
protective effects might derive from their abundant
secretion of the CXCL5 cytokine (16). In the present
study, we repeated the protocol of using the cytokine
antibody array for the analysis of secreted cytokines
in both EdU-labeled and unlabeled ADSCs. The
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all 19 tested cytokines between our present and
previous studies, and this included the characteristic
high-level CXCL5 secretion. More importantly, we
observed no discernible difference in the level of
any of these cytokines between EdU-labeled and
unlabeled ADSCs.
One of the proposed mechanisms for the thera-
peutic effects of SCs is their ability to home in to
injury sites, and this homing mechanism is believed
to be primarily mediated by SDF-1 (22). In the case
with ADSCs, we have previously demonstrated the
expression of SDF-1 in injured tissues and the
appearance of ADSCs in the vicinity of SDF-1
expression after their systemic administration (3,20).
In the present study, we compared EdU-labeled and
unlabeled ADSCs for their ability to migrate toward
SDF-1. The results showed that both cell prepara-
tions were responsive to SDF-1, and there was no
discernible difference between them.
From the above discussion, it can be concluded
that EdU was non-toxic to ADSCs and did not
interfere with the differentiation, cytokine secretion
or migratory response of ADSCs to SDF-1. EdU
therefore appears to be a reliable label for tracking
transplanted cells. However, although we have not
observed EdU leakage (i.e., absorption by unlabeled
cells) in our routine experiments, this issue must be
addressed in a specifically designed experiment in
the future. Additionally, it would be of value to
investigate the in vivo differentiation potential and
migratory behavior of EdU-labeled ADSCs in other
experiments as well.
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